Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy

NCT04623502 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.

NCT NCT04623502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04623502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Lead sponsor
University of Texas Southwestern Medical Center
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2019
Completion date
September 30, 2027
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chromophobe renal cell carcinoma, clear cell carcinoma, fumarate hydratase deficiency, hereditary leiomyomatosis and renal cell cancer, hlrcc, kidney cancer, metastatic kidney cancer, metastatic urothelial carcinoma, papillary renal cell carcinoma, renal cell carcinoma, succinate dehydrogenase-deficient renal cell carcinoma, urothelial carcinoma